Masayoshi Nagata
Tokyo, 1418610, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
From ball to rover: Transformable palm-sized rover SORA-Q for autonomous lunar exploration.
Journal: Science robotics
Published: June 10, 2026
A Minimum 3-Year Follow-Up of Nivolumab-Plus-Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J-ENCORE Study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: January 18, 2026
Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer.
Journal: The Prostate
Published: September 22, 2025
Renal Functional Outcomes in Robot-Assisted Partial Nephrectomy with Minimum Layer Resection Using Virtual Three-Dimensional Image Assistance.
Journal: Journal of clinical medicine
Published: September 05, 2025
Predicting Biochemical Recurrence After Robot-Assisted Prostatectomy with Interpretable Machine Learning Model.
Journal: Journal of clinical medicine
Published: August 30, 2025
Differential detection rates of clinically significant prostate cancer in transition zone versus peripheral zone lesions: Implications for transperineal magnetic resonance imaging-targeted biopsy strategy.
Journal: Prostate international
Published: August 27, 2025
Pre-treatment monocytic myeloid-derived suppressor cells as predictive biomarkers for immune checkpoint inhibitor response in clear cell renal cell carcinoma.
Journal: Frontiers in immunology
Published: June 05, 2025
Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus study.
Journal: Journal for immunotherapy of cancer
Published: May 09, 2025
Prostate-Specific Antigen Decline Rate in the First Month Is a Timely Predictive Factor for Biochemical Recurrence After Robot-Assisted Radical Prostatectomy.
Journal: Cancers
Published: January 31, 2025
Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of Postmarketing Surveillance.
Journal: Cancer medicine
Published: December 06, 2024
Last Updated: 09/26/2026